Furthermore, calcitriol supplementation induced differential dose-dependent modulation of proliferative tumour phenotypes; this was associated with significant decreases in the viability of cancer cells and the activation of two key apoptotic pathways, i.e., caspase and Bcl/Bax. Here, BAX is linked to cancer.